Ignite Creation Date:
2025-12-25 @ 2:36 AM
Ignite Modification Date:
2025-12-26 @ 4:02 PM
Study NCT ID:
NCT00997334
Status:
COMPLETED
Last Update Posted:
2018-02-23
First Post:
2009-10-16
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Erlotinib Therapy and Subsequent Development of Mechanisms of Secondary Resistance in Patients With NSCLC
Sponsor:
David M. Jackman, MD
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2010-02
Start Date Type:
ACTUAL
Primary Completion Date:
2015-05
Primary Completion Date Type:
ACTUAL
Completion Date:
2017-01
Completion Date Type:
ACTUAL
First Submit Date:
2009-10-16
First Submit QC Date:
None
Study First Post Date:
2009-10-19
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2017-01-05
Results First Submit QC Date:
None
Results First Post Date:
2017-04-11
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2018-01-29
Last Update Post Date:
2018-02-23
Last Update Post Date Type:
ACTUAL